Individual variations in serum melatonin levels through time: implications for epidemiologic studies

• Published in: PloS one 2013-12, Vol.8 (12), p.e83208
• Main Authors: Nogueira, Leticia M, Sampson, Joshua N, Chu, Lisa W, Yu, Kai, Andriole, Gerald, Church, Timothy, Stanczyk, Frank Z, Koshiol, Jill, Hsing, Ann W
• Format: Article
• Language: English
• Subjects: Aged; Analysis; Anticancer properties; Body mass; Body Mass Index; Breast cancer; Cancer; Cancer research; Cancer screening; Carcinogens; Circadian rhythm; Circadian Rhythm - physiology; Circadian rhythms; Correlation; Correlation analysis; Correlation coefficient; Correlation coefficients; Disease prevention; Endocrinology; Epidemiology; Health care; Health risks; Humans; Hypertension; Longitudinal Studies; Lung cancer; Male; Medical screening; Melatonin; Melatonin - antagonists & inhibitors; Melatonin - blood; Men; Mens health; Middle Aged; Neoplasms - prevention & control; Obesity; Ovarian cancer; Ovarian carcinoma; Photoperiod; Physiology; Plasma; Population; Preventive medicine; Prostate; Prostate cancer; Rhythm; Risk Factors; Seasons; Serum levels; Shift work; Smoking; Smoking - adverse effects; Studies; Urine; Variance analysis; Womens health
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0083208

Melatonin, a marker for the circadian rhythm with serum levels peaking between 2AM and 5AM, is hypothesized to possess anti-cancer properties, making it a mechanistic candidate for the probable carcinogenic effect of circadian rhythm disruption. In order to weigh epidemiologic evidence on the association of melatonin with cancer, we must first understand the laboratory and biological sources of variability in melatonin levels measured in samples. Participants for this methodological study were men enrolled in the Prostate Lung Colorectal and Ovarian Cancer Screening Trial (PLCO). We measured serum melatonin levels over a five year period in 97 individuals to test if melatonin levels are steady over time. The Pearson correlation coefficient between two measures separated by 1 year was 0.87, while the correlation between two measures separated by 5 years was to 0.70. In an additional cross-sectional study of 292 individuals, we used Analysis of Variance to identify differences in melatonin levels between different lifestyle and environmental characteristics. Serum melatonin levels were slightly higher in samples collected from 130 individuals during the winter, (6.36±0.59 pg/ml) than in samples collected from 119 individuals during the summer (4.83±0.62 pg/ml). Serum melatonin levels were lowest in current smokers (3.02±1.25 pg/ml, p = 0.007) compared to never (6.66±0.66 pg/ml) and former (5.59±0.50 pg/ml) smokers whereas BMI did not significantly affect serum melatonin levels in this study. In conclusion, the high 5 year correlation of melatonin levels implies that single measurements may be used to detect population level associations between melatonin and risk of cancer. Furthermore, our results reiterate the need to record season of sample collection, and individual characteristics in order to maximize study power and prevent confounding.